MarginsXMarginsX
Home › Canada › CSE stocks › GLOW

Glow Lifetech Corp. (CSE: GLOW)

GLOW trades on the Canadian Securities Exchange in Life Sciences, headquartered in Ontario. Numbers below come from the TMX issuer list, Yahoo Finance closes and the Bank of Canada rate, each with its source.

Close · November 13, 2026
C$0.0350
0.00% on the day
Market cap (C$)
C$6.7M
TMX list, November 13, 2026
Market cap (US$)
US$4.7M
Nano cap at 1.4257 C$/US$
1-year return
-36.4%
-41.7% year to date

Issuer list, sector and C$ market cap: TMX Group TSX and TSXV listed companies, as of November 13, 2026. US$ figures convert C$ at 1.4257 C$ per US$, the Bank of Canada daily rate for November 13, 2026. Close and returns: Yahoo Finance daily closes for GLOW.CN, last bar 2026-11-13, computed by MarginsX.

Profile

FieldValue
TickerGLOW on the Canadian Securities Exchange
Yahoo symbolGLOW.CN
SectorLife Sciences, Biotechnology
HeadquartersOntario
ListedThe TMX list gives no listing date
Listing typeTMX leaves listing type blank for long-listed issuers
Shares outstanding192,435,552
Also listed onNo interlisting on the TMX list
Index membershipNot in an S&P/TSX index per the TMX list
SEC CIK0002049105
WebsiteNo company website on record

Returns

WindowReturn
1 day0.0%
1 week-12.5%
1 month-12.5%
3 months-22.2%
6 months-36.4%
Year to date-41.7%
1 year-36.4%
From 52-week high-46.2%
52-week rangeC$0.0350 to C$0.0650

Links

SEDAR+ is linked for searching only; nothing on this page is taken from it.

Recent Canadian filings by type

43 documents in 4 types. Each title links to the document at its source.

Annual financial statements (3)

DocumentTypeFiled
Financial Statements
Period Year ended December 31, 2025
Annual financial statements2026-04-07
Financial StatementsAnnual financial statements2025-04-30
Financial Statements
Period Q4 2021
Annual financial statementsNo date

Interim financial statements (4)

DocumentTypeFiled
Financial Statements
Period Q1 2022
Interim financial statementsNo date
Financial Statements
Period Q1 2021
Interim financial statementsNo date
Financial Statements
Period Q2 2021
Interim financial statementsNo date
Financial Statements
Period Q3 2021
Interim financial statementsNo date

MD&A (22)

DocumentTypeFiled
MD&AMD&A (annual)2026-04-07
MD&AMD&A (annual)2025-04-30
MD&A
Period Q4 2021
MD&A (annual)No date
MD&A
Period Q2 2022
MD&A (interim)No date

Other (14)

DocumentTypeFiled
Financial StatementsFinancial statements (period not stated)2026-08-25
Financial StatementsFinancial statements (period not stated)2026-05-25
Financial StatementsFinancial statements (period not stated)2025-08-28
Financial StatementsFinancial statements (period not stated)2025-06-04

Sources: Company investor-relations website (links only, documents not copied). Documents filed only on SEDAR+ are not copied here; search SEDAR+ for the full record.

Trading halts

No CIRO halt notices for this company in our data.

Source: Canadian Investment Regulatory Organization (CIRO), Halts/Resumptions newsroom, notices since 2024-10-15.

Upcoming events

No upcoming earnings date, call or meeting announced in the SEC filings and newswire releases we read.

Source: dates read from the company's SEC filings and newswire releases; each row links to the announcement.

US private placements (SEC Form D)

FiledSecuritiesSoldOfferedFiling
2024-12-18Equity, Option To Acquire, Security To Be Acquired, OtherUS$9KUS$15KSEC EDGAR

Source: SEC EDGAR Form D filings matched on SEC CIK. Amounts are US$ as filed.

Peers in Life Sciences

TickerCompanyExchangeMarket cap (C$)1 month1 year
AVCRAvricore Health Inc.TSXVC$6.3M-18.2%-10.0%
KNEKane Biotech Inc.TSXVC$6.2M0.0%-25.0%
JUMPLevelJump Healthcare Corp.TSXVC$6.1M0.0%-15.4%
AVNTAvant Brands Inc.TSXC$8.0M+13.5%-6.3%
RKVRakovina Therapeutics Inc.TSXVC$8.2M-15.9%+15.6%

The app has the price chart, every filing, private raises and the full peer set for GLOW.

Open in the app